The short answer
Since 8 April 2021, the European Union has banned aloe-emodin, emodin and aloe leaf preparations containing hydroxyanthracene derivatives—the plant’s laxative molecules—in foods and supplements. Senna, alder buckthorn, cascara and rhubarb are under scrutiny, and a 2026 draft proposes banning them too.
In practice, filtered aloe gel extracted from the centre of the leaf remains on sale. A “juice” containing the leaf’s yellow latex does not. And a senna “bowel regularity” supplement faces a double bind: it must stay below the dose recognised as effective, otherwise it is a medicine, and below a threshold for banned molecules that the plant naturally contains.
The EU General Court annulled these bans in 2024, but the Commission appealed and the rule remains enforced pending the final decision.
The reason boils down to one statement from the European Food Safety Authority (EFSA): these molecules must be considered genotoxic and carcinogenic unless proven otherwise, and no daily dose without health concerns could be established. On the other side, there is a benefit, but it has long been known and is sold elsewhere—in pharmacies, with a patient leaflet and a maximum treatment duration.
Gel, latex, whole leaf: three products under the same name
The aloe vera leaf contains two very different liquids, as noted in the International Agency for Research on Cancer monograph (IARC):
- latex: a bitter yellow sap just beneath the rind, rich in anthraquinones, used for centuries as a purgative
- gel: the clear pulp in the centre of the leaf, used on burns and wounds
- whole-leaf extract: obtained by grinding the entire leaf, including the rind and latex
IARC notes that the word “juice” is used interchangeably for latex and gel. Handy for a label. Much less handy for you.
Pure gel contains almost no hydroxyanthracene derivatives, only traces that contaminate it during extraction, according to a 2021 review of gel-based products. Manufacturers also clarify the liquid by filtering it, often through activated charcoal: this is “decolourisation”. The European regulation itself acknowledges that filtration processes can produce products containing these compounds only as impurities.
The difference is not theoretical. In a two-year study by the US National Toxicology Program, rats drank water containing 0.5, 1 or 1.5% non-decolourised whole-leaf extract. At the two highest doses, large-intestine adenomas and carcinomas were markedly more frequent than in control rats. At 0.5%, and in mice, there were none. On this basis, IARC classifies aloe vera whole-leaf extract as possibly carcinogenic to humans, Group 2B, in its monograph published in 2016. Human evidence is considered inadequate.
What Europe banned in 2021
Regulation (EU) 2021/468 of 18 March 2021 added four entries to the list of substances prohibited in foods:
- aloe-emodin and all preparations containing it
- emodin and all preparations containing it
- preparations from aloe leaves containing hydroxyanthracene derivatives
- danthron, a structurally related molecule
To establish what counts as presence, experts from the Member States adopted a threshold of 1 ppm, or 1 mg per kilogram of product, for aloe-emodin, emodin or aloin A and B. There was no transition period because the legislation targets genotoxic and carcinogenic substances, the government explained in a response published in December 2021. It also refused to allow manufacturers to sell off their stocks. The MP’s question put this market at around €100 million in turnover in France.
France already had an older rule. According to another ministerial response, the order of 24 June 2014 prohibits a daily serving of a supplement from providing as much of these derivatives as the recognised pharmacological dose. Above that, the product is classified as a medicine. Inspectors use the European Medicines Agency’s thresholds: 10 mg a day expressed as sennoside B, or 20 mg expressed as rhein.
Senna, alder buckthorn, cascara, rhubarb: the reprieve is ending
The 2021 regulation placed preparations of rhubarb root, senna leaf or fruit, and alder buckthorn or cascara bark under Union scrutiny. Manufacturers could submit safety data to EFSA.
Two of them submitted a dossier, and eleven genotoxicity studies were added during the public consultation. In 2024, EFSA reviewed them: all the genotoxicity studies were negative, but the tested preparations were poorly characterised and did contain a molecule that is genotoxic in living animals. The conclusion: the safety of these preparations cannot be established.
The Commission used this to draw up a draft regulation, submitted to the Council on 15 July 2026. It moves these four plants, in forms containing hydroxyanthracene derivatives, onto the prohibited substances list, with 12 months to sell off products already on the market. The European Parliament and the Council had until 15 October 2026 to object. As of 20 November 2026, I have not found its publication in the Official Journal: the ban is therefore not yet in force.
A ban annulled, but still enforced
There is a legal twist to the story. On 13 November 2024, the General Court of the European Union annulled most of the 2021 regulation in four cases brought by an aloe producer, manufacturers of herbal products and the French food supplements trade association. Only the entry on danthron survived.
The General Court does not say these plants are safe. It rules that the Commission misapplied the law: the legislation it relies on concerns intakes greatly exceeding those from a normal diet, and does not allow a substance to be banned at any quantity without a risk threshold.
The Commission appealed to the Court of Justice in January 2025, including in Case C-38/25 P. In the meantime, the rule stands. The Directorate-General for Food states in its 2024 inspection report that the regulatory basis remains applicable until the final decision.
32 recalls in France: what the data show
The food supplement recall observatory links 32 RappelConso notices to these molecules or plants, covering 21 brands. All were published between May 2022 and October 2023, according to data consulted on 14 November 2026.
It is a smaller wave than those involving ethylene oxide, with 354 recalls, or garcinia cambogia, with 118. But the details are revealing:
- 23 recalls in 2022, representing 27% of the year’s 85 supplement recalls within the observatory’s scope, and 9 in 2023
- 16 notices mention emodin or aloe-emodin, 10 aloin and 9 hydroxyanthracene derivatives in general
- 5 concern aloe juices or gels for drinking, the others capsules, tablets, powders or herbal teas
- 10 products have the word “transit” in their name, and 7 notices mention senna, 3 rhubarb
- 8 recalls were ordered by prefectural decree, the others were voluntary
One detail shows where the problem lies: three notices for senna products explain that the aloe-emodin or emodin detected comes from the senna itself. Meeting a 1 ppm threshold with a plant that naturally produces the banned molecule is an industrial challenge.
Official inspections confirm that the issue is not settled. In 2024, 4 of 90 products analysed were non-compliant. An organic aloe gel contained three times the aloin limit, a senna leaf infusion 23 times. “Bowel regularity” squares contained 2,230 ppm of aloe-emodin and supplied nearly 97 mg of these derivatives a day, expressed as rhein, compared with a pharmacological dose of 20 mg. A product with this name was recalled in October 2024, but because it is a food rather than a supplement, the observatory does not count it.
The Italian market shows the same pattern. In an analysis of 43 products published in 2025, one third contained measurable derivatives. The highest levels came from solid supplements containing senna, cascara, rhubarb or alder buckthorn, reaching 1,353 mg of aloins per kilogram. Most aloe drinks, meanwhile, were below the limit of quantification.
Two other observatory notices, for lapacho and moringa, mention an “anthraquinone”. According to their notices, these concern pesticide residues, not the laxative molecules discussed in this article.
Why the authorities are concerned
The laxative mechanism is well understood. According to the European Medicines Agency monograph (EMA), senna sennosides are not absorbed in the small intestine. Colon bacteria convert them into an active metabolite that speeds up bowel transit and prevents the colon from reabsorbing water and salt. Stools become softer within 6 to 12 hours, according to the NHS.
The concern lies elsewhere. In its 2018 opinion, EFSA noted that:
- emodin, aloe-emodin and danthron are genotoxic in laboratory tests, meaning they damage cellular DNA
- aloe-emodin is also genotoxic in living animals
- aloe whole-leaf extract and danthron are carcinogenic in animals
- epidemiological data suggest an increased risk of colorectal cancer among laxative users
It concluded that it could not propose any daily dose without health concerns.
There are counterarguments, and they matter. A 2021 study from the University of Milan found no genotoxicity from aloe-emodin in mice at doses up to 2,000 mg per kilogram per day, without ruling out oxidative damage in the colon. The EMA, which assesses senna as a medicine, also writes that the genotoxicity of senna and aloe-emodin has not been proven in living animals.
In humans, a 2018 case-control study involving 4,930 patients found an approximately twofold higher risk of colorectal cancer among regular users of non-fibre laxatives, and no association with fibre-based laxatives. This type of study does not prove causation: constipation can precede a cancer diagnosis, and not all non-fibre laxatives contain these derivatives.
So the uncertainty is real. But it does not weigh equally on both sides. A medicine taken for a week for constipation has a benefit that justifies a poorly understood risk. A “detox” juice drunk every morning does not.
The United States acted earlier, and more bluntly. In 1998, the FDA asked manufacturers for genotoxicity and carcinogenicity studies on aloe and cascara. According to the decision published in 2002, nobody submitted any. Both were removed from over-the-counter laxatives.
The real everyday risk: prolonged use
The most concrete danger is not cancer, which remains a hypothesis in humans. It is what we might call the Toll: the hidden cost of a solution, here the price of a daily bowel movement delivered by a stimulant.
The EMA spells it out for senna:
- dependence: prolonged use can disrupt bowel function and make laxatives indispensable
- potassium loss: laxative abuse lowers potassium, which enhances the effects of digitalis medicines used for heart conditions, and interacts with antiarrhythmics
- interactions: diuretics, corticosteroids and liquorice worsen this potassium loss, and the EMA calls for medical advice before combining senna with medicines that prolong the QT interval
- the kidneys: long-term use can cause water and salt imbalances, or protein or blood in the urine
- the liver: chronic overdoses of these laxatives can cause toxic hepatitis
It also reports pigmentation of the bowel wall, pseudomelanosis coli, which generally disappears after stopping use.
Oral aloe has its own liver case reports, all isolated cases. A 73-year-old woman developed acute hepatitis while taking aloe capsules for constipation, which resolved after she stopped. A Korean team described three women affected after several months of taking an aloe preparation, and another team described a 21-year-old patient after four weeks. These are isolated cases, suggesting a link without measuring its frequency, but they are a reminder that “natural” does not mean “inert”. The article on supplements that really do pose a hepatitis risk · FR gives the signs to watch for.
Reading the label of a bowel supplement
Before buying, or when sorting through your cupboard, a few checks are enough:
- botanical names : Cassia senna or Senna alexandrina (senna), Rhamnus frangula or Frangula alnus (alder buckthorn), Rhamnus purshiana (cascara), Rheum (rhubarb), Aloe ferox or aloe latex
- the part of the aloe used : a reputable aloe drink specifies inner gel or pulp, filtered or decolorized, and ideally its aloin content
- the promises : “detox,” “flat stomach” or “bowel regularity,” a claim carried by 10 of the 32 recalled products
- the duration : a several-week “course” of a laxative plant goes against the one-week limit set for medicinal use
- the blends : two recalls involved products combining aloe powder and senna leaves
If a product ticks several boxes, look it up in the monitoring database. The recalls involving these plants date from 2022 and 2023, but supplements have an average shelf life of three years, according to the parliamentary question cited earlier.
Slimming teas have another, even more serious catch: secretly added medicines that have been withdrawn from the market, the subject of the article on slimming coffees and aphrodisiac honeys.
What actually works for constipation
The irony of these supplements is that they take up space that other solutions fill better. The NHS recommends starting with diet and habits:
- gradually increase fiber, for example with wheat bran, oats or flaxseeds
- eat fruits containing sorbitol, such as apples, apricots, grapes, raspberries or strawberries
- drink enough fluids
- keep a regular toilet routine and do not ignore the urge to go, ideally with your feet raised on a small stool
- move every day—a walk is enough
Trials support this advice. In a meta-analysis of 16 trials involving 1,251 adults with constipation, 66% responded to fiber supplements compared with 41% in the control groups. Psyllium and pectin were the most effective, especially at more than 10 g per day and for at least 4 weeks. The price to pay: more gas.
A second meta-analysis from 2024 looked at foods. Kiwifruit increased bowel movement frequency slightly more than psyllium, prunes matched it, and mineral-rich water produced more treatment responses than low-mineral water. Trials remain few in number. To choose the right fiber for your needs, the soluble and insoluble fiber chart · FR gives portion details.
If that is not enough, the NHS advises trying a bulk-forming laxative first, based on fiber such as ispaghula. Osmotic laxatives, such as macrogol or lactulose, take 2 to 3 days to work. The EMA reserves senna for cases where diet and bulk-forming laxatives are not enough, and only for short-term use.
What about aloe gel drinks? A 2018 meta-analysis of 3 small trials involving 151 patients suggests a modest improvement in irritable bowel syndrome symptoms. As for “detox,” no trial even defines it, let alone measures it.
When to seek medical advice
Constipation is common and often harmless, but some signs go beyond self-care:
- seek medical advice promptly if abdominal pain comes with nausea or vomiting: the EMA warns that these signs may indicate a bowel obstruction and that you should not take a laxative without medical advice
- see your doctor if you have blood in your stool, unexplained weight loss, persistent fatigue or a sudden change in bowel habits, according to the NHS
- bring it up too if you need a laxative every day: the EMA says the cause should then be investigated
- seek advice before taking any stimulant laxative if you take heart medication, a diuretic or corticosteroids, have kidney disease, are pregnant or are breastfeeding





